Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment options--development of consensus guidelines.

M Lecha1, I Effendy, M Feuilhade de Chauvin

  • 1Servicio de Dermatologia, Hospital Clinic I Provincial de Barcelona, Villarroel, Barcelona, Spain.

Journal of the European Academy of Dermatology and Venereology : JEADV
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nail clipping may not be sufficient to corroborate the diagnosis of psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Tangential biopsy of the nail bed and matrix, with plate evaluation, for diagnosis of lichen planus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Nail lichen planus: A review of clinical presentation, diagnosis and therapy.

Annales de dermatologie et de venereologie·2022
Same author

Longitudinal subungual acanthoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Abrikossof granular cell tumor at the nail unit: An exceptional location.

Annales de dermatologie et de venereologie·2021
Same author

Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany.

The British journal of dermatology·2020
Same journal

Environmental criteria in dermatology research grants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Diabetes and melanoma: Impact on prognosis and healthcare costs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Differential survival with adjuvant immunotherapy in stage III acral versus non-acral melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Estimating the global burden of mental health disorders associated with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles

Combination therapy offers the best cure rates for onychomycosis (fungal nail infection). Treatment decisions for fungal nail infections depend on severity and nail involvement, guiding topical or oral antifungal choices.

Area of Science:

  • Dermatology
  • Mycology
  • Pharmacology

Background:

  • Onychomycosis (fungal nail infection) has three main treatment strategies: topical, oral, and combination therapy.
  • Amorolfine nail lacquer is effective for topical monotherapy, but combination therapy yields superior mycological and clinical cure rates.
  • Newer antifungals (triazoles, echinocandins) allow for novel treatment protocols.

Purpose of the Study:

  • To review current onychomycosis treatment options.
  • To develop a practical management algorithm for daily clinical practice.

Main Methods:

  • Literature review of available onychomycosis therapies.
  • Development of a clinical decision-making algorithm based on established criteria.

Related Experiment Videos

Main Results:

  • Treatment selection for onychomycosis depends on patient factors, etiology, and disease extent.
  • Topical monotherapy is suitable for <50% nail involvement without matrix disease.
  • Oral or combination therapy is recommended for >50% nail involvement, including the matrix, or when topical drug delivery is compromised.

Conclusions:

  • Treatment decision-making tools, such as illustrated guides, can support effective onychomycosis management.
  • Tailoring treatment regimens based on specific onychomycosis characteristics is crucial for successful outcomes.